TY  - RPRT
TI  - Targeting Anti-HLA Class I and II Antibodies with CAR-B Cell Therapy: A Novel Strategy to Mitigate Graft Rejection and Platelet Refractoriness
AU  - Kesherwani, V.
PY  - 2025
DO  - 10.1101/2025.02.20.639042
UR  - https://www.biorxiv.org/content/10.1101/2025.02.20.639042v1
ID  - 10.1101/2025.02.20.639042
ER  -